Daniel Liebler

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read More

In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives. Read More

Mitochondria not only are the cell’s main power producers, they are also the chief cooks and bottle washers. Read More

Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications. Read More

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. Read More

Daniel Liebler, Ph.D., Ingram Professor of Cancer Research, professor of Biochemistry, and director of the Ayers Institute for Precancer Detection and Diagnosis, has been selected as one of 96 fellows of the American Chemical Society (ACS), the world’s largest scientific society. Read More

Archived tissue samples are yielding new disease biomarkers. Read More